Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score).


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 31 8 2020
medline: 1 1 2021
entrez: 31 8 2020
Statut: ppublish

Résumé

This is the first study to show a stepwise increase in venous thrombotic events according to COVID-19 coagulopathy (COVID-19-associated hemostatic abnormalities [CAHA]) staging and lung injuries assessed by chest computed tomography. Excess mortality and/or transfer to intensive care unit according to CAHA staging.

Identifiants

pubmed: 32862411
doi: 10.1055/s-0040-1715836
pmc: PMC7869051
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

1716-1719

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

M.O. reports personal fees from Canon Medical Systems Europe, outside the submitted work.

Références

J Thromb Haemost. 2020 Jun;18(6):1517-1519
pubmed: 32294295
Thromb Haemost. 2020 Jul;120(7):1004-1024
pubmed: 32473596
Thromb Haemost. 2020 Jun;120(6):998-1000
pubmed: 32316063
Thromb Haemost. 2020 May;120(5):876-878
pubmed: 32246450
J Thromb Haemost. 2020 Jul;18(7):1747-1751
pubmed: 32302448
Lancet Rheumatol. 2020 Jul;2(7):e437-e445
pubmed: 32835247
Radiology. 2020 Sep;296(3):E189-E191
pubmed: 32324102
Crit Care Resusc. 2020 Apr 15;22(2):95-97
pubmed: 32294809
Res Pract Thromb Haemost. 2020 Jul 06;4(5):731-736
pubmed: 32685880
Thromb Haemost. 2020 Jun;120(6):937-948
pubmed: 32316065
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Eur Radiol. 2020 Sep;30(9):4903-4909
pubmed: 32314058
Thromb Haemost. 2020 Jun;120(6):949-956
pubmed: 32349133

Auteurs

Benjamin Marchandot (B)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Antonin Trimaille (A)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Anaïs Curtiaud (A)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Adrien Carmona (A)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Kensuke Matsushita (K)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
INSERM (French National Institute of Health and Medical Research), Regenerative Nanomedicine, FMTS, Strasbourg, France.

Chisato Sato (C)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
INSERM (French National Institute of Health and Medical Research), Regenerative Nanomedicine, FMTS, Strasbourg, France.

Ian Leonard-Lorant (I)

Radiology Department, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Laurent Sattler (L)

Department Laboratory Haematology, Centre for Thrombosis and Haemostasis, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Lelia Grunebaum (L)

Department Laboratory Haematology, Centre for Thrombosis and Haemostasis, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Mickaël Ohana (M)

Radiology Department, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Patrick Ohlmann (P)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Laurence Jesel (L)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
INSERM (French National Institute of Health and Medical Research), Regenerative Nanomedicine, FMTS, Strasbourg, France.

Olivier Morel (O)

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
INSERM (French National Institute of Health and Medical Research), Regenerative Nanomedicine, FMTS, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH